Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Overdracht van ESBL-producerende Enterobacteriaceae naar huisgenoten
apr 2021 | Antibioticaresistentie, Bacteriële infecties